Antibody targeting of claudin-1 as a potential colorectal cancer therapy

BACKGROUND: Metastatic colorectal cancer (mCRC) is one of the major causes of cancer-related death. Despite the substantial progress in mCRC management, it remains important to identify new therapeutic options and biological markers for personalized medicine. Here, we investigated the expression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherradi, S., Ayrolles-Torro, A., Vezzo-Vié, N., Gueguinou, N., Denis, V., Combes, E., Boissière, F., Busson, M., Canterel-Thouennon, L., Mollevi, C., Pugnière, M., Bibeau, F., Ychou, M., Martineau, P., Gongora, C., Del Rio, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490170/
https://www.ncbi.nlm.nih.gov/pubmed/28659146
http://dx.doi.org/10.1186/s13046-017-0558-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490170/
https://www.ncbi.nlm.nih.gov/pubmed/28659146
http://dx.doi.org/10.1186/s13046-017-0558-5

Ejemplares similares